425: SLB Advances ChampionX Acquisition with Proposed Remedies to UK Regulator

SLB is progressing with its acquisition of ChampionX, proposing divestitures and commercial remedies to address concerns raised by the UK Competition and Markets Authority (CMA).

Summary

• SLB announced that the UK Competition and Markets Authority (CMA) will consider its proposed actions to address concerns regarding the ChampionX acquisition as part of the Phase 1 review.
• The proposed actions include the divestiture of ChampionX's U.S. Synthetic business, already approved by U.S. regulators.
• SLB also proposes divesting all of its production chemicals business in the United Kingdom, representing less than 1% of the transaction's value.
• Commercial remedies for the Quartzdyne business are suggested, including long-term supply agreements and licensing of intellectual property.
• SLB anticipates closing the acquisition in Q2 or early Q3 of 2025.
• The initial agreement to purchase ChampionX was announced in April 2024.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the acquisition is progressing, but regulatory hurdles remain. The proposed remedies suggest a proactive approach to address concerns.

Positives

• The CMA's willingness to consider SLB's proposals is a positive step towards completing the acquisition.
• The proposed divestitures and remedies appear designed to address regulatory concerns effectively.
• The anticipated closing timeline of Q2 or early Q3 2025 provides clarity for investors.
• The U.S. Synthetic business divestiture has already been approved by U.S. regulators.

Negatives

• The need for divestitures and remedies indicates potential regulatory hurdles to the acquisition.
• The divestiture of SLB's UK production chemicals business, while small, represents a loss of assets.
• The acquisition closing is not yet guaranteed and remains subject to regulatory approval.

Risks

• The CMA could reject SLB's proposed remedies, potentially delaying or preventing the acquisition.
• Other regulatory bodies may raise concerns, requiring further concessions from SLB.
• Unforeseen events or circumstances could lead to the termination of the acquisition agreement.
• The integration of ChampionX's business may not be as seamless as anticipated, impacting synergies and value creation.

Future Outlook

SLB anticipates closing the acquisition of ChampionX in Q2 or early Q3 of 2025, subject to regulatory approvals and other closing conditions.

Management Comments

• SLB is pleased with this further progress and will continue its collaboration with the CMA and other regulators toward an anticipated closing in Q2 or early Q3.

Industry Context

The acquisition of ChampionX is part of a broader trend in the oilfield services industry towards consolidation and the integration of digital technologies to enhance efficiency and production optimization. SLB aims to strengthen its position in the market by combining its expertise with ChampionX's portfolio.

Comparison to Industry Standards

• Comparable mergers in the oilfield services sector, such as Baker Hughes' acquisition of GE Oil & Gas, have faced similar regulatory scrutiny, often requiring divestitures to address competition concerns.
• The proposed divestiture of SLB's UK production chemicals business is similar to actions taken by other companies to satisfy regulators in past mergers.
• The size of the ChampionX acquisition is significant, positioning SLB as a major player in the production and midstream chemicals market, similar to competitors like Halliburton and Ecolab.

Stakeholder Impact

• Shareholders of both SLB and ChampionX are awaiting the completion of the acquisition.
• Employees of both companies may experience changes as a result of the integration.
• Customers of both companies can expect a broader range of products and services.
• Suppliers may be affected by changes in procurement strategies following the merger.

Next Steps

• SLB will continue to collaborate with the CMA and other regulators.
• SLB will work towards satisfying the closing conditions for the acquisition.
• The company anticipates closing the acquisition in Q2 or early Q3 of 2025.

Key Dates

Keywords

SLB, ChampionX, acquisition, CMA, divestiture, regulatory approval, merger, oilfield services, production chemicals, Quartzdyne